Authors

• Steven Tam
• Robin G. Jennings
• Carolyn Revta
• Robert A. Rissman (ORCID: https://orcid.org/0000-0001-9245-8278)
• Edmond Teng (ORCID: https://orcid.org/0000-0002-1375-857X)
• Judy Pa (ORCID: https://orcid.org/0000-0002-5788-9352)
• Howard Feldman (ORCID: https://orcid.org/0000-0002-9258-4538)
• Rosemary Morrison
• Joshua D. Grill (ORCID: https://orcid.org/0000-0002-4215-7589)
• Kim N. Green (ORCID: https://orcid.org/0000-0002-6049-6744)
• Sarah Kremen (ORCID: https://orcid.org/0000-0003-2593-0602)
• Karen Messer (ORCID: https://orcid.org/0000-0002-9298-2413)
• Aimee Pierce (ORCID: https://orcid.org/0000-0002-9423-366X)
• Maryam Beigi (ORCID: https://orcid.org/0000-0002-4070-2109)
• Jing Zhang (ORCID: https://orcid.org/0000-0002-1578-3760)
• Gabriel C. Léger (ORCID: https://orcid.org/0000-0001-7900-3957)
• Daniel L. Gillen (ORCID: https://orcid.org/0000-0003-1983-9730)
• Beatriz Vides
• Shelia Jin
• Archana Balasubramanian
• Gaby Thai

Institutions

• University of California, Irvine (US)

Publication Details

Journal

Neurology

Published

2024-12-13

DOI

https://doi.org/10.1212/wnl.0000000000210152

Citations

14

Primary Topic

Tryptophan and brain disorders

Type

article

Field-Weighted Citation Impact

2.20

Funders

• Eli Lilly and Company
• Biogen
• Arrowhead Pharmaceuticals
• Consortium canadien en neurodégénérescence associée au vieillissement
• Eisai
• Novo Nordisk
• Genentech
• University of California, San Diego
• University of California, Irvine
• Office of the President, University of California
• National Institute on Aging